Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Umeclidinium/Vilanterol (125/25 mcg) in Japanese COPD Patients
NCT01376388Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Anoro Ellipta in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Aug 2011; status: completed.
02
Drugs
Anoro Ellipta
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01376388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376388.